Cargando…

Novaferon, treatment in COVID-19 patients

Detalles Bibliográficos
Autores principales:	Janapala, Rajesh Naidu, Patel, Jigar, Belfaqeeh, Omar, Alhashmi, Abdulla, Pourmand, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688290/ https://www.ncbi.nlm.nih.gov/pubmed/33248244 http://dx.doi.org/10.1016/j.ijid.2020.11.180

Ejemplares similares

Organizational characteristics: Effect on outcome of ICU COVID-19 patients in Belgium
por: Patel, Jigar, et al.
Publicado: (2021)

Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study
por: Janapala, Rajesh Naidu, et al.
Publicado: (2021)

Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting
por: Janapala, Rajesh Naidu, et al.
Publicado: (2021)

Azithromycin, a questionable treatment for COVID-19
por: Belfaqeeh, O., et al.
Publicado: (2021)

Reply to “Novaferon, treatment in COVID-19 patients”
por: Zheng, Fang, et al.
Publicado: (2021)

Therapeutic anticoagulation in COVID-19 patients
por: Belfaqeeh, O., et al.
Publicado: (2021)

COVID-19: could CT provide the best population level biomarker? Incidental COVID-19 in major trauma patients suggests higher than predicted rates of infection in London
por: Alhashmi, A., et al.
Publicado: (2021)

SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial
por: Zheng, Fang, et al.
Publicado: (2020)

Novaferon Effectively Inhibits Ancestral SARS-CoV-2 and Omicron Variant in Vitro, 2022
por: Ye, Fei, et al.
Publicado: (2022)

High-dose budesonide for early COVID-19
por: Berezowski, Ivan, et al.
Publicado: (2021)

Azithromycin for mild-to-moderate COVID-19
por: Patel, Jigar, et al.
Publicado: (2021)

Novaferon, a novel recombinant protein produced by DNA-shuffling of IFN-α, shows antitumor effect in vitro and in vivo
por: Li, Meng, et al.
Publicado: (2014)

Vitiligo Treatment in Ancient Iranian Medicine
por: POURMAND, Mohammad, et al.
Publicado: (2016)

Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site
por: Qaseem, Aisha, et al.
Publicado: (2019)

Effectiveness of COVID-19 vaccines
por: Syed, Mohamed Ahmed, et al.
Publicado: (2022)

Reply to Letter: factors affecting COVID-19 outcomes in patients with congenital heart disease
por: Jeilani, Hammad, et al.
Publicado: (2021)

A case series of precipitous cardiac tamponade from suspected perimyocarditis in COVID-19 patients
por: Kogler, William, et al.
Publicado: (2021)

Pancreatoblastoma Masquerading as a Retroperitoneal Germ Cell Tumor
por: Rassiwala, Muffazzal, et al.
Publicado: (2017)

COVID‐19‐vaccinated plasma treatment for COVID‐19 patients?
por: Alberca, Gabriela Gama Freire, et al.
Publicado: (2021)

Providing Safe and Effective Surgical Care During the COVID-19 Outbreak in the UK – Changing Strategies
por: Chapman, Robert, et al.
Publicado: (2020)

Treatment impact on COVID-19 evolution in hemodialysis patients
por: Chawki, Sylvain, et al.
Publicado: (2020)

The Low Yield of SARS-CoV-2 Rapid Antigen Testing in Screening Asymptomatic Hospital Visitors in Low-incidence Settings
por: Boddeti, Nymisha L., et al.
Publicado: (2022)

Drug-induced Reduction of Gamma Carboxylation in Osteocalcin: What is the Fallback?
por: Usman, Norina, et al.
Publicado: (2019)

Single-best Choice Between Intermittent Versus Continuous Renal Replacement Therapy: A Review
por: Fathima, Nida, et al.
Publicado: (2019)

COVID-19: Neuromuscular Manifestations
por: Benny, Rajesh, et al.
Publicado: (2021)

Response to the article by Dietz et al. entitled “Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID‑19 pandemic. The COVID‑19 pandemic breast cancer consortium”
por: Beitsch, Peter, et al.
Publicado: (2020)

COVID-19 vaccination in immunocompromised patients
por: Sonani, Bhavin, et al.
Publicado: (2021)

Vax-Plasma in Patients With Refractory COVID-19
por: Ordaya, Eloy E., et al.
Publicado: (2022)

Inter-hospital transfer of a pregnant prone patient with COVID-19 as a bridge to ECMO
por: Nasa, Prashant, et al.
Publicado: (2022)

Patients with COVID-19: are current isolation guidelines effective enough?
por: Patel, K.P., et al.
Publicado: (2020)

Preserving the “human touch” in times of COVID-19
por: Sagar, Rajesh, et al.
Publicado: (2020)

Prone Position Effects in the Treatment of Covid-19 Patients
por: Rahmani, Farzad, et al.
Publicado: (2020)

Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
por: Nakaya, Aya, et al.
Publicado: (2022)

Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
por: Nakaya, Aya, et al.
Publicado: (2023)

Telepsychiatry in the Arabian Gulf region - Implications beyond the Covid-19 pandemic
por: Karim, Mustafa Abdul, et al.
Publicado: (2020)

Diabetic Ketoacidosis in Patients With COVID-19
por: Rao, Sanjana, et al.
Publicado: (2021)

Yoga for COVID – 19
por: Patel, Nupur B., et al.
Publicado: (2021)

Colchicine as a Potential Treatment Choice for COVID-19 Patients in Developing Countries: COVID-19 and Colchicine
por: Ghang, Byeongzu, et al.
Publicado: (2022)

Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia
por: Tatar, Erhan, et al.
Publicado: (2020)

COVID-19: Airway management considerations
por: Herman, Jared, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ppd27vdtbsa823afj2vb05jdss